5 Conclusion From the perspective of Chinese healthcare payers, our findings suggest that once-daily oral semaglutide as an add-on therapy is likely to be a more cost-effective option than most injectable GLP-1 RAs in China, excluding injectable semaglutide and exenatide, for patients with T2DM who have inadequate control on basal insulin
Data annotation : As mentioned in the previous section, this phase is used to label data collected from social media
Your order will have priority in preparation compared to others
Conclusion Over the past decades, cardiology has become increasingly hyper-specialised, leading to fundamental innovations such as advancements in cardiac imaging, percutaneous techniques, ablation and in the understanding of the genetics of cardiomyopathies
Despite testimonials and anecdotal evidence to the contrary, more scientific research is required to confirm the efficacy of GHK-Cu peptides